Conference

Immuno-Oncology Scientific Symposium

Laboratory Considerations for Immuno-Oncology (I-O) and Companion Diagnostics (CDx) Development

Shanghai, China | October 16, 2019 - October 16, 2019 | 13:30 - 17:00 Add to Calendar
Stay Informed Schedule a Meeting

About This Event

Join our Chief Scientific Officer, Patrice Hugo, Ph.D., and our team of scientific advisors as they discuss laboratory services solutions for Immuno-Oncology drug and companion diagnostic development. This complimentary I-O scientific symposium will cover current topics and issues around immuno-oncology, and will include an integrated session between a panel of experts and the audience.

Agenda Outline
  • Laboratory Considerations for Immuno-Oncology and Companion Diagnostics Development
  • Integrating Molecular Profiling into Biomarker Strategy
  • Anatomic Pathology for Developing Biomarkers for Immuno-Oncology
  • Next Generation Immuno-Oncology Flow Cytometry
  • Companion Diagnostics for I-O Clinical Development
  • Successful Delivery of IO Biomarkers for Clinical Development in China
View agenda and speaker details here.


Interested in being part of a panel discussion? Contact us here.


Q2 Solutions reserves the right to determine the appropriateness of an individual’s request for attendance.